EUVIMEDEUVIMED entdecken
Validierungsstudie

Development and validation of a rapid HPLC‐MS/MS method for simultaneous determination of cyclosporine A and tacrolimus in whole blood for routine therapeutic drug monitoring in organ transplantation

Fei-Fei Han iD, Hong-Chuan Liu, Ting Hu, Peng-Fei Li, Rui Zhao, Zhuo-Ling An

Rapid Communications in Mass Spectrometry · 2025

DOI: 10.1002/rcm.9932 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Rapid Communications in Mass Spectrometry, 2025. Verfasst von Fei-Fei Han und 5 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Tacrolimus, Tandem Mass Spectrometry, Cyclosporine, Drug Monitoring. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Therapeutic drug monitoring is an integral part of organ transplantation. A rapid, simple, economical, and robust high‐performance liquid chromatography‐tandem mass spectrometry (HPLC‐MS/MS) method for simultaneously determining the immunosuppressants cyclosporine A and tacrolimus might increase detection efficiency.

Methods

In this study, we developed and validated a rapid HPLC‐MS/MS method. Whole blood samples of 100 μL were prepared by protein precipitation with acetonitrile and 0.5 mol. L −1 ZnSO 4 . Chromatography was performed on a pre‐column using a gradient elution with 20 mmol. L −1 ammonium formate and 0.1% (v/v) formic acid in water (mobile phase A) and 0.1% (v/v) formic acid in methanol (mobile phase B) at a flow rate of 1.5 mL.min −1 . The analysis time was 2.2 min. Electrospray ionization and multiple reaction monitoring were performed. The lower limit of quantification was set at 1 ng. L −1 for tacrolimus and 50 ng. L −1 for cyclosporine A.

Results

The method showed adequate accuracy and precision with a sufficient linear range. The calibration curve range of tacrolimus and cyclosporine A was 1–30 and 50–1500 ng·mL‐ 1 , respectively. All correlation coefficients were >0.99.

Conclusions

The developed HPLC‐MS/MS is rapid and can be used for simultaneous monitoring of tacrolimus and cyclosporine A.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TacrolimusTandem Mass SpectrometryCyclosporineDrug MonitoringImmunosuppressive AgentsChromatography, High Pressure LiquidHumansReproducibility of ResultsOrgan TransplantationLimit of DetectionLinear ModelsLiquid Chromatography-Mass Spectrometry

Substanzen

TacrolimusCyclosporineImmunosuppressive Agents

Autor:innen und Institutionen

  • Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.

ORCID-Profile: Fei-Fei Han

Zitieren

APA

Han, F. F., Liu, H. C., Hu, T., Li, P. F., Zhao, R., & An, Z. L. (2025). Development and validation of a rapid HPLC‐MS/MS method for simultaneous determination of cyclosporine A and tacrolimus in whole blood for routine therapeutic drug monitoring in organ transplantation. Rapid Communications in Mass Spectrometry. https://doi.org/10.1002/rcm.9932

Vancouver

Han FF, Liu HC, Hu T, Li PF, Zhao R, An ZL. Development and validation of a rapid HPLC‐MS/MS method for simultaneous determination of cyclosporine A and tacrolimus in whole blood for routine therapeutic drug monitoring in organ transplantation. Rapid Communications in Mass Spectrometry. 2025. doi:10.1002/rcm.9932

BibTeX
@article{Han2025,
  author = {Han, Fei-Fei and Liu, Hong-Chuan and Hu, Ting and Li, Peng-Fei and Zhao, Rui and An, Zhuo-Ling},
  title = {Development and validation of a rapid HPLC‐MS/MS method for simultaneous determination of cyclosporine A and tacrolimus in whole blood for routine therapeutic drug monitoring in organ transplantation},
  journal = {Rapid Communications in Mass Spectrometry},
  year = {2025},
  doi = {10.1002/rcm.9932}
}
Kostenlos starten →